MedPath

Charité - Universitätsmedizin Berlin

Charité - Universitätsmedizin Berlin logo
🇩🇪Germany
Ownership
Private
Established
1710-01-01
Employees
10K
Market Cap
-
Website
http://www.charite.de

A Non-invasive Approach to the Assessment of Volume Status in Mechanically Ventilated Septic Patients.

Completed
Conditions
Severe Sepsis
Septic Shock
First Posted Date
2006-11-14
Last Posted Date
2009-07-15
Lead Sponsor
Charite University, Berlin, Germany
Registration Number
NCT00398736

Referral Recommendations for Axial Spondyloarthritis

Completed
Conditions
Spondyloarthropathy
Ankylosing Spondylitis
Spondyloarthritis
First Posted Date
2006-10-03
Last Posted Date
2013-02-13
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
500
Registration Number
NCT00383617
Locations
🇩🇪

Department of Rheumatology, Medical Clinic I, Charite Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany

11ß-HSD1 and Metabolic Syndrome

Phase 2
Completed
Conditions
Impaired Glucose Tolerance
Metabolic Syndrome
Interventions
First Posted Date
2006-08-31
Last Posted Date
2018-01-16
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
24
Registration Number
NCT00370305
Locations
🇩🇪

Charite, Campus Benjamin Franklin, Berlin, Germany

HAI Via Interventionally Implanted Port Catheter Systems

Phase 2
Conditions
Colorectal Cancer
Liver Neoplasms
Hepatocellular Carcinoma
Gallbladder Cancer
Bile Duct Cancer
First Posted Date
2006-07-25
Last Posted Date
2006-07-25
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
100
Registration Number
NCT00356161
Locations
🇩🇪

Klinik für Radiologie und Nuklearmedizin, Otto-von-Guericke Universität Magdeburg, Magdeburg, Germany

🇩🇪

Charité Centrum Tumormedizin, Medizinische Klinik für Hämatologie und Onkologie, CVK, Berlin, Germany

Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

Phase 4
Completed
Conditions
Chronic Heart Failure
First Posted Date
2006-07-04
Last Posted Date
2007-10-31
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
36
Registration Number
NCT00347087
Locations
🇩🇪

Applied Cachexia Research, Cardiology Dept. Charite Medical School, Virchow Klinikum, Berlin, Germany

Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia

Phase 2
Conditions
Chronic Lymphocytic Leukemia
Interventions
Procedure: allogeneic stem cell transplantation
First Posted Date
2006-06-16
Last Posted Date
2009-01-29
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
82
Registration Number
NCT00337519
Locations
🇩🇪

Uniklinikum Carl Gustav Carus, Dresden, Germany

🇩🇪

Klinikum Chemnitz gGmbH, Chemnitz, Germany

🇩🇪

Deutsche Klinik für Diagnostik GmbH, Wiesbaden, Germany

Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia

Phase 2
Conditions
Dystonia
Movement Disorder
Interventions
Procedure: deep brain stimulation
First Posted Date
2006-05-31
Last Posted Date
2009-03-04
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
24
Registration Number
NCT00331669
Locations
🇩🇪

Andreas Kupsch, Berlin, Germany

Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)

Conditions
Spondylarthropathy
Spondyloarthritis
Spondylitis, Ankylosing
First Posted Date
2006-05-19
Last Posted Date
2013-02-13
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
992
Registration Number
NCT00328068
Locations
🇨🇳

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

🇨🇦

University of Alberta, Edmonton, Alberta, Canada

🇨🇦

The Toronto Hospital, Toronto, Ontario, Canada

and more 31 locations

Sports in Hypertension of the Elderly

Not Applicable
Completed
Conditions
Hypertension
First Posted Date
2006-04-18
Last Posted Date
2006-04-18
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
54
Registration Number
NCT00315224
Locations
🇩🇪

Charité, Campus Benjamin Franklin, Berlin, Germany

Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)

Phase 4
Completed
Conditions
Osteoporosis, Postmenopausal
Interventions
Drug: ibandronate, calcium and vitamin D
Drug: placebo,calcium and vitamin D
First Posted Date
2006-01-04
Last Posted Date
2009-01-28
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
70
Registration Number
NCT00271713
Locations
🇩🇪

Centre for Muscle and Bone Research, Charité - Campus Benjamin Franklin, Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath